Cargando…

Long non-coding RNA CDKN2B antisense RNA 1 gene inhibits Gemcitabine sensitivity in bladder urothelial carcinoma

Objective: To investigate the clinical significance of long noncoding RNA (lncRNA) CDKN2B antisense RNA 1 (CDKN2B-AS) gene and its effects on Gemcitabine sensitivity in BUC. Materials and Methods: The expression of CDKN2B-AS gene was examined with real-time quantitative PCR. The cell proliferation a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Dalong, Zhang, Hui, Shang, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010684/ https://www.ncbi.nlm.nih.gov/pubmed/29937935 http://dx.doi.org/10.7150/jca.25236

Ejemplares similares

Knockdown of long non-coding RNA Taurine Up-Regulated 1 inhibited doxorubicin resistance of bladder urothelial carcinoma via Wnt/β-catenin pathway
por: Xie, Dalong, et al.
Publicado: (2017)

Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma
por: Shang, Chao, et al.
Publicado: (2019)

Circular RNA CircHIPK3 Promotes Gemcitabine Sensitivity in Bladder Cancer
por: Xie, Fang, et al.
Publicado: (2020)

MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2
por: Li, Bo, et al.
Publicado: (2019)

Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder
por: Wang, Xiaoming, et al.
Publicado: (2020)

Non-coding RNA NEAT1/miR-214-3p contribute to doxorubicin resistance of urothelial bladder cancer preliminary through the Wnt/β-catenin pathway
por: Guo, Yan, et al.
Publicado: (2018)

Are Antisense Long Non-Coding RNA Related to COVID-19?
por: Badr, Eman A E, et al.
Publicado: (2022)

Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma
por: Wang, Jiawu, et al.
Publicado: (2019)

The Landscape of Long Non-Coding RNA Dysregulation and Clinical Relevance in Muscle Invasive Bladder Urothelial Carcinoma
por: Shen, Haotian, et al.
Publicado: (2019)

Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter
por: Ou, Minghui, et al.
Publicado: (2020)

Natural Antisense Transcripts and Long Non-Coding RNA in Neurospora crassa
por: Arthanari, Yamini, et al.
Publicado: (2014)

Long non-coding RNA linc00665 inhibits CDKN1C expression by binding to EZH2 and affects cisplatin sensitivity of NSCLC cells
por: Yang, Daolu, et al.
Publicado: (2021)

BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma
por: Parasramka, Mansi, et al.
Publicado: (2017)

A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer
por: Xue, Yao, et al.
Publicado: (2014)

Long non-coding RNA muskelin 1 antisense RNA as a potential therapeutic target in hepatocellular carcinoma treatment
por: Chen, Xijun, et al.
Publicado: (2022)

The long non-coding RNA LINC00460 predicts the prognosis and promotes the proliferation and migration of cells in bladder urothelial carcinoma
por: Wen, Lijie, et al.
Publicado: (2019)

Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2017)

Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression
por: Li, Haocheng, et al.
Publicado: (2019)

An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients
por: Sun, Zhuolun, et al.
Publicado: (2020)

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2023)

RETRACTED ARTICLE: Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis
por: Liu, Zhongyuan, et al.
Publicado: (2018)

Retraction Note: Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis
por: Liu, Zhongyuan, et al.
Publicado: (2022)

HOXC Cluster Antisense RNA 3, a Novel Long Non-Coding RNA as an Oncological Biomarker and Therapeutic Target in Human Malignancies
por: Xie, Yunhe, et al.
Publicado: (2023)

Role of long non-coding RNA-adducin 3 antisense RNA1 in liver fibrosis of biliary atresia
por: Ye, Yongqin, et al.
Publicado: (2022)

Association of Myocardial Infarction with CDKN2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 Polymorphism in Slovenian Subjects with Type 2 Diabetes Mellitus
por: Tibaut, Miha, et al.
Publicado: (2022)

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Kim, Hongsik, et al.
Publicado: (2023)

Endogenous intronic antisense long non-coding RNA, MGAT3-AS1, and kidney transplantation
por: Nagarajah, Subagini, et al.
Publicado: (2019)

Long Non-coding Wilms Tumor 1 Antisense RNA in the Development and Progression of Malignant Tumors
por: Zhang, Ye, et al.
Publicado: (2020)

Co‐delivery of microRNA‐21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy
por: Li, Yaqing, et al.
Publicado: (2017)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
por: Sung, Hyun Hwan, et al.
Publicado: (2022)

Long non-coding RNA VIM Antisense RNA 1 (VIM-AS1) sponges microRNA-29 to participate in diabetic retinopathy
por: Zeng, Feng, et al.
Publicado: (2020)

The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer
por: Li, Zhihua, et al.
Publicado: (2015)

The long non-coding RNA keratin-7 antisense acts as a new tumor suppressor to inhibit tumorigenesis and enhance apoptosis in lung and breast cancers
por: Zhao, Zhe, et al.
Publicado: (2023)

Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
por: Chen, Chen, et al.
Publicado: (2022)

Knockdown of microRNA-130b improves doxorubicin sensitivity in bladder urothelial carcinoma by negatively regulating cylindromatosis expression
por: Li, Bo, et al.
Publicado: (2019)

Characterization of a Long Non-Coding RNA, the Antisense RNA of Na/K-ATPase α1 in Human Kidney Cells
por: Fan, Xiaoming, et al.
Publicado: (2018)

Involvement of long non-coding RNA ZNF503 antisense RNA 1 in diabetic retinopathy and its possible underlying mechanism
por: Han, Ting, et al.
Publicado: (2022)

LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma
por: Liu, Zhongyuan, et al.
Publicado: (2017)

Analysis of Long Non-Coding RNA in Cryptosporidium parvum Reveals Significant Stage-Specific Antisense Transcription
por: Li, Yiran, et al.
Publicado: (2021)

Long non-coding RNA HLA-F antisense RNA 1 inhibits the maturation of microRNA-613 in polycystic ovary syndrome to promote ovarian granulosa cell proliferation and inhibit cell apoptosis
por: Li, Xiaohua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qonpbb690k88edojua8hou9gua